抗癌药物蓖麻油提取物的气相色谱分析

文[1]曾报道将蓖麻油提取物精制品制成乳剂和多相脂质体,进行动物体内外抗癌活性实验,结果表明该提取物具有较强的抗癌活性,但其抗癌活性成分的组成和含量尚不清楚.本实验就蓖麻油提取物的组成和含量进行气相色谱分析.     

一种含稀土锰钢的热处理和低温韧性研究

本文研究了加稀土5％Mn钢的热处理、组织和机械性能,探索其部分代替9Ni钢使用于-196℃的可能性,并以同样成分的无稀土钢作为对比,研究稀土在该钢中的作用。     

耐火砖模具的稀土高浓度渗碳

在煤油渗剂中添加微量稀土元素对A3钢耐火砖模具进行稀土高浓度渗碳 ,可使渗速加快 ,渗层碳浓度增高 ,层深尤其是过共析 共析层深度增加 ;渗层硬度较高且硬度梯度较缓 ;渗层组织中的碳化物数量增多 ,且呈细小颗粒状弥散分布。生产实践表明 ,经该工艺处理的耐火砖模具 ,使用寿命可比常规气体渗碳处理的提高2— 3倍。     

微连接用无铅钎料及稀土在钎料中的应用现状

综述了微连接用无铅钎料的应用研究现状，指出SnAgCu系合金因良好的综合性能将成为最有潜力的锡铅钎料替代品。基于对稀土在钎料中应用研究成果的分析，认为添加微量稀土有望成为改善SnAgCu系无铅钎料蠕变性能的重要途径。充分利用我国丰富的稀土资源开发低Ag的SnAgCuRE系钎料，应当成为中国今后无铅钎料研究开发的重点。     

稀土化学与灯用三基色荧光粉的发展

本文简要介绍了稀土概况及发光机理，概述了灯用稀土三基色蒌光粉的发展应用情况，及其市场发展现状与前景。     

固相微萃取膜(SPMEE)在滥用药物检验中的应用

介绍一种全新的SPMEE技术SPMEE法，并对其在滥用药物检验中的应用进行了初步探讨。     

In vitro amiodarone protein binding and its interaction with warfarin

Summary The binding of amiodarone to human plasma protein and to bovine serum, albumin was studied by three different methods, ultracentrifugation, equilibrium dialysis and fluorescence spectroscopy. The fraction of amiodarone bound to plasma protein amounted to 96.3%. The changes in the binding properties of 1-anilino-naphthalene-8-sulfonate for bovine serum albumin using warfarin and amiodarone as independent inhibitors were analyzed in terms of binding site specificity. The findings indicated that amiodarone and warfarin have two different binding sites on bovine serum albumin, so a noncompetitive inhibition mechanism was indicated. On the basis of our data we cannot exclude other mechanisms of interaction besides direct displacement of one drug by another; nevertheless, metabolite interference between amiodarone and coagulation cofactors may better explain the enhancement of warfarin's pharmacological action in association with amiodarone.This work was partially funded by the CNR (National Research Council, Rome, Italy), Program on Clinical Pharmacology and Rare Diseases. The authors would like to thanks Drs E. Marzi and E. riva for their help.     

耐碳青霉烯酶肺炎克雷伯菌的分离鉴定及生物学特性分析

以临床尿路感染患者尿液为研究对象,通过分离培养及16s rDNA进行肺炎克雷伯菌的分离鉴定;采用Kirby-Bauer纸片法进行药敏实验,并对分离株进行碳青霉烯酶表型筛选;通过PCR检测常见的碳青霉烯酶耐药基因、荚膜血清型和毒力基因分布情况;对分离的肺炎克雷伯菌株进行了生物被膜形成能力及其对小鼠致病力的分析。本研究从采取的86例尿液标本中分离检出11株耐碳青霉烯酶肺炎克雷伯菌,分离率为12.79%。耐碳青霉烯酶基因PCR检测结果显示,blaNDM、blaVIM、blaIMP和blaKPC基因在分离株中均呈现不同程度的分布。耐药性分析发现11株肺炎克雷伯菌对氨苄西林耐药率为90.91%,对头孢噻肟耐药率为63.64%,对链霉素、庆大霉素、氯霉素和诺氟沙星的耐药率较低。耐碳青霉烯类肺炎克雷伯菌荚膜分型结果显示,分离的11株细菌中10株均为强毒力型菌株（90.9%）,其中K57血清型4株（36.4%）,K1血清型1株（9.1%）,K2血清型1株（9.1%）,K5血清型1株（9.1%）,K20血清型3株（27.3%）,提示该批分离株具有较强的致病力。此外,毒力因子分布结果显示,其毒力因子rmpA（54.5%）、Aerobactin F（54.5%）在菌株中分布较为广泛。生物被膜形成能力检测及小鼠致病性试验结果显示,9株分离株均有较强的生物被膜形成能力,菌株致病力可能与荚膜血清型及生物被膜形成能力相关。综上所述,临床分离的致尿路感染病原肺炎克雷伯菌呈现多重耐药特征,强毒力菌株以K57荚膜型为主,K1、K2均有分布,提示对尿路感染病原应加强耐药监测,合理使用抗菌药物,有效防控多重耐药和强毒力菌株的感染与流行。     

Retention of topical liposomal formulations on the cornea

Summary The ability of liposomes composed of different kinds of phospholipid materials to adhere to the surface of the cornea was studied in the rabbit. The liposomes were labelled with tracer amounts of an I¹²⁵-labelled phosphatidylethanolamine derivative and were instilled in 10 l drops onto the cornea. The retention of radioactivity was monitored. The results show that liposomes containing positively charged phospholipids are better retained than an albumin control. Thus, it may be possible to develop a drug delivery, liposome system which would permit long-term sustained release of ophthalmic drugs onto the cornea.